Intuitive Surgical's stock fell 28%, prompting an upgrade from Hold to Buy due to its position in the fast-growing surgical robotics market, expected to nearly triple by 2033. Despite its premium valuation, the company's consistent revenue and profit growth, along with strong management execution, support a bullish outlook. Risks include competition from Medtronic and Chinese firms, margin pressures, and market volatility that could affect stock multiples. The upgrade reflects confidence in the company's long-term growth prospects despite recent stock weakness.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
